Development and evaluation of computerized chemosensory-based orbitofrontal cortex training (cbot) for relapse preventionin patients with opioid use (OUD)
Ended Project Grant Awarded Last action
- Award ID
- R43DA049616
- Recipient
-
Evon Medics LLC UEI KE4NA95F3HF9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $223,907
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Funding
-
- $224,271.20 Federal
- -$364.40 Non-federal
- Place of performance
- Elkridge, MD 21075, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$364 | $0 | |
| Amendment | -$364 | -$364 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $225,000 | $0 |
Quick answers
Who received award R43DA049616?
R43DA049616 was awarded to Evon Medics LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2019.
How much is award R43DA049616 worth?
$223,907 has been obligated on R43DA049616: $224,271 in federal funding and -$364 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award